SG Americas Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $485K | Sell |
|
|||||
|
2023
Q1 | $778K | Buy |
|
|||||
|
2022
Q4 | $264K | Sell |
|
|||||
|
2022
Q3 | $203K | Sell |
|
|||||
|
2022
Q2 | $273K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $131K | Sell |
|
|||||
|
2021
Q3 | $1.36M | Buy |
|
|||||
|
2021
Q2 | $502K | Buy |
|
|||||
|
2021
Q1 | $193K | Sell |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $845K | Buy |
|
|||||
|
2020
Q2 | $578K | Sell |
|
|||||
|
2020
Q1 | $830K | Buy |
|
|||||
|
2019
Q4 | $555K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $241K | Sell |
|
|||||
|
2019
Q1 | $251K | Sell |
|
|||||
|
2018
Q4 | $171K | Buy |
|